['choroidal neovascularization']
['faricimab', 'ranibizumab', 'sham procedure']

        Inclusion Criteria:

          -  Treatment-naive with CNV secondary to AMD, with subfoveal CNV or juxtafoveal CNV with
             a subfoveal component related to the CNV activity by FFA or SD-OCT

          -  Active CNV

        Exclusion Criteria:

          -  CNV due to causes other than AMD

          -  Subretinal hemorrhage, fibrosis, or atrophy involving either the fovea or more than
             50% of the total lesion area

          -  Cataract surgery within 3 months of baseline, or any other previous intraocular
             surgery

          -  Major illness or surgery within 1 month prior to Screening

          -  Glycosylated hemoglobin (HbA1c) above 7.5%

          -  Uncontrolled blood pressure
      